Cloning and characterization of the human and mouse homologues of the Drosophila CDP-diacylglycerol synthase (eye-CDS) gene. by Halford, S, Dulai, K, Fitzgibbon, J, Hunt, D

Isolation and chromosomal localization of two human CDP-diacylglycerol synthase (CDS) genes. by Halford, S, Dulai, K, Daw, S, Fitzgibbon, J, Hunt, D

Segmental uniparental disomy is a commonly acquired genetic event in relapsed acute myeloid leukemia. by Raghavan, M, Smith, L, Lillington, D, Chaplin, T, Kakkas, I, Molloy, G, Chelala, C, Cazier, J, Cavenagh, J, Fitzgibbon, J, Lister, T, Young, B

SNP RS6457327 ON CHROMOSOME 6P PREDICTS TRANSFORMATION OF FOLLICULAR LYMPHOMA by Wrench, J, Skibola, C, Matthews, J, Cazier, J, Iqbal, S, Carlotti, E, Calaminici, M, Davies, A, Montoto, S, Gribben, J, Lister, A, Fitzgibbon, J

SNP rs6457327 in the HLA region on chromosome 6p is predictive of the transformation of follicular lymphoma. by Wrench, D, Leighton, P, Skibola, C, Conde, L, Cazier, J, Matthews, J, Iqbal, S, Carlotti, E, Bödör, C, Montoto, S, Calaminici, M, Gribben, J, Lister, T, Fitzgibbon, J

Mutations of the PU.1 Ets domain are specifically associated with murine radiation-induced, but not human therapy-related, acute myeloid leukaemia. by Suraweera, N, Meijne, E, Moody, J, Carvajal-Carmona, L, Yoshida, K, Pollard, P, Fitzgibbon, J, Riches, A, van Laar, T, Huiskamp, R, Rowan, A, Tomlinson, I, Silver, A

Early loss of CREBBP confers malignant stem cell properties on lymphoid progenitors by Huntly, B, Horton, S, Giotopoulos, G, Yun, H, Vohra, S, Sheppard, O, Bashford-Rogers, R, Rashid, M, Sasca, D, Basheer, F, Gallipoli, P, Okosun, J, Hodson, D, Fitzgibbon, J, Du, M, Adams, D

Immediate chest X-ray for patients at risk of lung cancer presenting in primary care: randomised controlled feasibility trial. by Neal, RD, Barham, A, Bongard, E, Edwards, RT, Fitzgibbon, J, Griffiths, G, Hamilton, W, Hood, K, Nelson, A, Parker, D, Porter, C, Prout, H, Roberts, K, Rogers, T, Thomas-Jones, E, Tod, A, Yeo, ST, Hurt, CN

Regions of acquired uniparental disomy at diagnosis of follicular lymphoma are associated with both overall survival and risk of transformation. by O'Shea, D, O'Riain, C, Gupta, M, Waters, R, Yang, Y, Wrench, D, Gribben, J, Rosenwald, A, Ott, G, Rimsza, L, Holte, H, Cazier, J, Johnson, N, Campo, E, Chan, W, Gascoyne, R, Young, B, Staudt, L, Lister, T, Fitzgibbon, J

KDM5 inhibition offers a novel therapeutic strategy for the treatment of KMT2D mutant lymphomas by Heward, JA, Koniali, L, D'Avola, A, Close, K, Yeomans, A, Philpott, M, Dunford, JE, Rahim, T, Al Seraihi, AF, Wang, J, Korfi, K, Araf, S, Iqbal, S, Bewicke-Copley, F, Kumar, E, Barisic, D, Calaminici, M, Clear, AJ, Gribben, JG, Johnson, PWM, Neve, RM, Cutillas, PR, Okosun, J, Oppermann, U, Melnick, A, Packham, G, Fitzgibbon, J

Early loss of Crebbp confers malignant stem cell properties on lymphoid progenitors by Horton, S, Giotopoulos, G, Yun, H, Vohra, S, Sheppard, O, Bashford-Rogers, R, Rashid, M, Clipson, A, Chan, W, Sasca, D, Yiangou, L, Osaki, H, Basheer, F, Gallipoli, P, Burrows, N, Erdem, A, Sybirna, A, Foerster, S, Zhao, W, Sustic, T, Petrunkina Harrison, A, Laurenti, E, Okosun, J, Hodson, D, Wright, P, Smith, K, Maxwell, P, Fitzgibbon, J, Du, M, Adams, D, Huntly, B